MENU

MTNB Matinas Biopharma Holdings Inc Forecast, Technical & Fundamental Analysis

a manufacturer of pharmaceutical products

Industry Biotechnology
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published Earnings

MTNB is expected to report earnings to rise 25.00% to -2 cents per share on November 06

Matinas Biopharma Holdings Inc MTNB Stock Earnings Reports
Q3'24
Est.
$-0.03
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.03
Q4'23
Beat
by $0.01
Q3'23
Est.
$-0.03
The last earnings report on August 14 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 21.57K shares outstanding, the current market capitalization sits at 3.18M.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1545 Route 206 South
Phone
+1 908 484-8805
Employees
32
Web
https://www.matinasbiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

MTNB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MTNB has been closely correlated with TPST. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTNB jumps, then TPST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
-10.65%
TPST - MTNB
78%
Closely correlated
+0.36%
REGN - MTNB
38%
Loosely correlated
-2.71%
LIANY - MTNB
34%
Loosely correlated
-0.03%
EQ - MTNB
31%
Poorly correlated
-12.33%
INO - MTNB
31%
Poorly correlated
-3.64%
More

Groups containing MTNB

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
-10.65%
MTNB
(2 stocks)
95%
Closely correlated
-5.59%
drugs
(254 stocks)
27%
Poorly correlated
-1.67%
biotechnology
(238 stocks)
13%
Poorly correlated
-1.76%
pharmaceuticals
(159 stocks)
10%
Poorly correlated
-1.90%